Skip to main content
Clinical Trials/DRKS00009944
DRKS00009944CompletedPhase 3

Assessment of non-invasive vagal nerve Stimulation (VNS)-induced head pain-effects in refractory migraine patients: a multimodal fMRI study - nVNS fMRT refractory migraine

FE Klinische Funktionelle Neurobildgebung, Experimentelle Radiologie Radiologische Universitätsklinik Bonn0 sites44 target enrollmentStarted: February 8, 2016Last updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Sponsor
Enrollment
44

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomized controlled study
Masking
Blinded (masking used)

Eligibility Criteria

Ages
20 Years to 60 Years (—)
Sex
All

Inclusion Criteria

  • Male / Female subjects
  • - Right-handedness
  • - Oral and written informed consent
  • - Stable headache medication 4 weeks prior to study entry
  • - Refractory to drug / behavior therapy / psychiatric therapies
  • -confirmed diagnosis according to IHCD-3 beta
  • -Willing to fullfil follow-up investigations

Exclusion Criteria

  • - Neurological diseases, current and / or history (including severe craniocerebral trauma.)
  • - Abuse or dependence of analgesic / psychotropic substances including alcohol (except nicotine) in the history or current
  • - Severe psychiatric disorders in history and currently, serious physical disorders, especially unstable cardiovascular disorders
  • - Claustrophobia
  • - Non-removable ferromagnetic metallic implants, probes, stimulators, prostheses, pacemakers, large tattoos, etc.
  • - Age <25 or> 60 years
  • - Neuromodulation treatment in prehistory

Investigators

Sponsor
FE Klinische Funktionelle Neurobildgebung, Experimentelle Radiologie Radiologische Universitätsklinik Bonn

Similar Trials